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The sever i ty of  the bleeding disorders Haemophi l ia A and B is a ref lect ion
of the essent ia l  ro le of  factors VII I  and IX in blood coagulat ion.  The two
pro te ins  par t i c ipa te  in  the  in t r ins ic  ac t i va t ion  o f  fac to r  X ,  a  reac t ion .
which further requires the presence of a membrane surface containing
negat ively charged phosphol ip ids (see ref .  I  for  a review).  In v ivo,  b lood
platelets provide such a surface.
Methods to prepare high' ly pur i f ied factors IX and X are avai lable,  and
the molecu'lar changes in the zymogens IX and X when they are converted to
the act ive ser ine proteases factors IXa and Xa are known (1,2).  The struc-
ture of  human factor VII I :C (coagu' lant) ,  the molecule that  cor:rects haemo-
phi l ia A is not yet  known (see ref  3 for  a review).  Studies on bovine
factor VII I  indicate a molecular weight of  about 220.000 and the presence
of  th ree  pept ide  cha ins  in  the  ac t iva ted  fac to r  V I I I  (4 ) .  Fac tor  V I I I :WlF
is a molecule di f ferent f rom factor VII I :C. I t  is  def ic ient  in van
Hi l lebrands disease, and funct ions in the adhesion of  b lood platelets to,
damaged endothel ium. Factor VII I :Vl , lF is also designated as factor VII I :RAG
(factor VII I  re ' lated ant igen) and as the r istocet in cofactor act iv i ty.  In
p' lasma and cryoprecipi tate factor VII I :Vl , lF and factor YII I :C are found
assoc ia ted  in  the  so  ca l led  fac to r  V l l l : complex  (3 ) .  In  our  s tudy  we have
used pur i f ied bovine factor VII I :C and factor VII I  compTex. Unt i l  now no
di f ferences in factor X act ivat ing act iv i ty between the preparat ions have
been found. The phosphol ip ids used in th is work are uni lamel lar  (s ingle
b i layer )  ves ic les  ob ta ined by  son ica t ion  o f  l ip id  suspens ions  cons is t ing  o f
25% phosphat idylser ine and 75% phosphat idylchol ine.
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in t r ins ic  fac to r  X  ac t iva t ing  conp lex .
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tine course of factor X activation-
I t  i s  thought  tha t  dur ing  ac t iva t ion  the  fac to rs  IXa VI I Ia  and X are
bound at  the phosphol ip id surface. Factors IXa and X are equipped with
10-12  mod i f ied  g lu tamic  ac id  res idues  (gammacarboxy  g lu tamic  ac id
residues),  that  enables these proteins to bind to the negat ively charged
phosphol ip ids of  the membrane surface via a Ca2+-br idge (Fig.  1.)  Ihe
in te rac t ion  o f  fac to r  V I I I  w i th  l ip ids  has  no t  been inves t iqa ted  in  de ta i ' | .  *
Faetor X act ivat ion can be fol lowed on a spectrophotometer using the
chromogen' ic substrate 52337. Factor Xa hydrolyses this substrate l iberat ing
parani t roani l ine,  that  absorbs at  405 nm. The rate of  52337 conversion is
proportional with the amount of factor Xa present.
Factor VII I  must be act ivated before i t  can part ic ipate in factor X
act ivat ion.  In f ig.  2 is shown the t ime course of  factor X act ivat ion by
factor IXa in the presence of  PL, C^2* and factor VII I .  l l i th unact ivated
fac tor  V I I I  (c losed c i rc les)  a  1ag per iod  is  seen wh ich  most  l i ke ly
ref lects the t ime required for factor VII I  act ivat ion in the react ion
mix tu re ,  s ince  pre incubat ion  o f  fac to r  V I I I  w i th  fac to r  Xa (1  rM,  5  min .
37o) in presence of  phosphol ip ids and Ca2+ pr ior  to addi t ion of  factors IXa
and X abol ished the ' lag per iod.  The lag is also abol ished af ter  a 1 m' in
incubat ion of  factor VII I  wi th 1.5 nM thrombin.  In al l  fur ther exper iments
we use thrombin act ivated factor VII I .
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Kinetics of factor X act ivat ion
To further understand of  the roles of  factor VII I  and of
and Ca?+ in the conversion of factor X to Xa by factor
determined the kinetic parameters for several different factor
mixtures.  The resul ts are surmarized in table 1,
phosphol i pids
IXa, we have
X ac t iva t ing
Composi t ion of  factor X
act ivat ing mixture
KmaPP Vnax
pM mol Xa.min- l .mol
Ixa-1
4.002?
0.0105
0.00247
500
IXa
IXa,  CaC1,  
*
IXa,  CaCl  r ,PL
IXa ,  CaCl2 ,  PL
VI I Ia (11
(10 uM)
( 10 rril) ,
units/m' l  )+
299
181
0.058
0.063
PL,  Phospho l ip id ,  *  V I I Ia ,  fac to r  V I I I  complex  ac t iva ted  w i th  th rombin .
Table 1:  Ef fect  of  the accessory components (phosphol ip ids,  CaCl,  and
factor VII Ia)  on the k inet ic parameters of  factor X act ivat ion.  (data f rom:
van Diei jen et  a l  1981; ref .  5)
Both phosphol ip id and factor VII Ia cause important changes of  the
kinet ic parameters of  factor X act ivat ion.  In the presence of  phosphol ip ids
the Km drops from 181 uM to 0.058 uM, wi th l i t t le change of  Vmax. The
l -4-ef fect  of  factor VII Ia is mainly on Vmax, which is increased about 200.000fold.  The physiological  importance of  the accessory components is c lear,
consider ing the plasma factor X concentrat ion of  0.2 yFI.  Phosphol ip ids are
required to br ing the Km for factor X wel l  below the plasma concentrat ion
and factor VII I ,  which increases the Vmai ' is  required to obtain substant ia l
levels of  factor Xa.
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Fig. 3 l , trcdel to explain the lowering of
Knr in presence of a negatively charged
phospho l ip id  sur face .
Fig .3 .  p rov ides  an  exp lanat ion  why the  Km for  fac to r  X  is  lowered in
presence of  a phosphol ip id surface. In solut ion (upper panel  )  a high
concentration of factor X is required to saturate the enzyme factor Xa.
l lhen l ip ids and Caz+ are present ( lower panel)  both factor IXa and factor X
bind to the l ip id surface. Hence, the local  factor X concentrat ion is
highly increased. Since Km is expressed in terms of  added factor X, i t  is
c lear that  in presence of  l ip ids much lower amounts of  factor X are
required to obtain hal f  maximal rates of  factor X act ivat ion.
Assays based on the intr insic factor X act ivat ing system
The knowledge of  the k inet ic propert ies of  the factor X act ivat ing system
has enabled us to design assays for phosphol ip ids,  factor IXa, and factor
VII Ia.  In the assays exper imental  condi t ions were selected such that the
rate of  factor X act ivat ion is proport ional  wi th the component o be
assayed.
,
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Fig .  4  Pr inc ip le  and exper imenta l  cond i t ions
for the spectrophotometric determination of
factor IX in plasma. Data from ref. 5 and 7.
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Fig. 5 Calibrat ion curves obtained with
various amounts of refer€nce plasma, counarin
p lasma and fac to r  IX ,  V I I ,  and VI I I  de f ic ien t
plasmas in the spectrophotometric assay for
factor IX.
Fig. 6 Relat ionship betneen the factor IX
activi ty determined with the chronogenic
method and the activi ty in thronbotest, in
plasma of 98 long-tenn anticoagulated human
subjects.
-Assay of  factor IX in plasma. The method consists of  three steps. (Fig.
4 ) .  D i lu ted  p lasma is  incubated  w i th  contac t  p roduc t  ( fae tor  X Ia) ,  dur ing
this step factor IX is completely converted to factor IXa. A sample of  the
ac t i va ted  p lasma i s  then  incuba ted  w i th  fac to r  X  in  p resence  o f
phosphol ip ids and CaZ*.  Af ter 30 min factor X act ivat ion is stopped with
EDTA and the amount of factor Xa present is determined with the chromogenic
subsrate 52337. From a cal ibrat ion curve made with known amount of  act ive
si te t i t rated factor IXa, the amount of  factor IXa in the plasma can be
cal  cul  ated.
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Fig.  5 shows that the factor IX act iv i ty in the assay is propor: t ional  wi th
the amount of  p lasma: that  factor IX def ic ient  p lasma has no act iv i ty;  that
the assay is not inf luenced by presence or absence of  factors VII  and VII I
and that lower act iv i t ies are found in plasma from pat ients receiv ing
coLmarin.  [n Fig.  6 is plot ted the factor IX content determined in plasrna
of 98 pat ients receiv ing long term oral  ant icoagulants,  versus the act iv i ty
as determined with thrombotest .  The desirable therapeut ical  range based on
thrombotest is between 5 and !2.5%, which corresponds to Z3-4gX of the
factor IX act iv i ty in reference plasma as determined with the chromogenic
assay. There is good agreement between the two methods, S0 out of 98
pat ients,  would receive the same instruct ions wi th regards to dosage. These
resul ts and a comparison with spectrophotometr ic methods for factor I I ,  VI I
and X is  g iven  in  van D ie i jen-V isser  e t  a l  (7 ) .  The pr inc ip le  o f  the  method
is given in Tans et  a l .  Thrombos. and Haemostas.  In press (6).
-  Assay  o f  fac to r  V I I I  in  p lasma
The pr inc ip le  o f  the  assay  is  ou t l ined  in  F ig .  7 .  D i lu ted  p lasma is  incu-
bated  w i th  th rombin  to  ac t iva te  a l l  fac to r  V I I I  to  V I I Ia .  a  sample  is  added
to  a  mix tu re  o f  fac to rs  IXa,  X  and phospho l ip ids  p lus  CaCl2 .Fac tor  X  ac t i -
vation is stopped with EDTA, and the amount of factor Xa formed is
determined with 52337.
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Fi9 .  7  Pr inc ip le  and exper imenta l  cond i t ions
for the sF€ctrophotometric determination of
fac to r  V I : I  in  p lasma.
F i9 .  B  Ca l ib ra t ion  curves  ob ta ined w i th
various amounts of bovine and human plasma,
and w i th  h igh ly  pur i f ied  bov ine  fac tb r  V I I i :C ,
rn the spectrophotometric assay for factor VIII .
I -7 -As  shown in  f ig .8  a  l inear  re la t ionsh ip  i s  fgund be tween the  amount  o fplasma and the rate of  factor Xa format ion in the test .  Bovine plasma gives
5 t imes higher act iv i t ies than human plasma. Bovine plasma may contain 5
t imes more  fac to r  V I I I ,  o r  a l te rna t ive ly  the  bov ine  fac to r  V I I I  mo lecu le  i s
more act ive than i ts human counterpart .  The insert  is  the act iv i ty of  a
h igh ly  pur i f ied  bov ine  fac to r  V I I I :C  prepara t ion  conta in ing  29  nH o f  fac to r
VI I I :C  (Method to  be  pub l ished) .  .
This al ' lowed us to conclude that the factor VII I  concentrat ion in bovine
p lasma is  1 .1  nM or  0 .?4  ng /1 .  $ lhen the  molecu la r  we igh t  o f  fac to r  V I I I  i s
220.000 this would resul t  in a speci f ic  c lot t ing act iv i ty of  4L32 U/mg.
This is ident ical  to the speci f ic  act iv i ty reported by Vehar and Davie (4).
Ro le  o f  b lood p la te le ts  in  in t r ins ic  fac to r  X  ac t iva t ion
The act iv i ty of  p latelets in factor X act ivat ion was studied using
washed human platelets,  that  were st imulated for var ious t ime per iods wi th
var ious agonists.  A mixture of  factors IXa, VII Ia,  X and CaZ+ was then
added and the rate of factor Xa formation was determined with a chromogenic
substrate.
P la te le t  o r  phospho l ip id  p re-
parat i on
Rate of fXa
format ion (nM/min)
Unst imulated platelets (2.SxtO6/ml )
Soni cated pl ate'l ets
Pl atel et I i  p' id extract ( 1 pM )
Ves ic les  o f  p la te le t  phospho l ip id
compos i t ion  (1  uM)
0.3
31.  5
33.6
34.2
Table 2:  Ef fect  of  p latelets and platelet  phosphol ip ids on the rate of
factor Xa formation.
As  shown in  tab le  2  uns t imu la ted  washed p la te le ts  have l i t t le  ac t i v i t y  in
fac to r  X  ac t iva t ion .  Pur i f ied  phospho l ip id  ves ic les ,  ves ic les  o f  p la te le t
l ip id  compos i t ion  and p la te le t  phospho l ip id  ex t rac t  a re  h igh ly  ac t i ve .
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Platelets become act ive af ter  d isrupt ion by sonicat ion.  This resul t  is
explained by the fact  that  the platelet  phosphol ip ids are asyrmetr ical ly
distr ibuted over the inner and outer leaf lets of  the platelet  membrane
phospho l ip id  b i layer  (F ig .  9 ) .  The  nega t i ve ty  charged  phospho l ip ids ,
phosphat idylser ine and phosphat idyl inosi thol  are almost al l  located at  the
cytoplasmic s ide of  the platelet  membrane and therefore inaccessible for
interact ion wi th the c lot t ing factors present in plasma (see ref . .8 f rom
review).  However,  when platelets are st imulated by the combined act ion of
co l lagen p lus  th rombin ,  ac t i v i t y  appears  in  fac to r  X  ac t iva t ion .  Thrombin
a lone is  no t  an  e f f i c ien t  s t imu lan t  (F ig .  10) .
a
6ltt"g.nt"nd thrombln
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Fig. 9 Glycero-phospholipid composit ion of the
outer monolayer of the platelet plasma nembrane.
PS,  phosphat idy lser ine ;  PE,  phosphat idy le thano l -
amine;  PC,  phosphat idy lcho l ine ;  P I ,  Phosphat idy l -
inosithol.  Data from Zvaal and Hemker ef. 8.
T ime o f  p la te le t  s t imu la t ion  (  m in  )
Fig. 10 Tjme course of appearance of platelet
factor X activating activi ty. Platelets rere
ac t iva ted ,  wh i le  s t i r r ing ,  w i thout  agon is t  w i th
I Ia  o r  w i th  Co l lagen/ I la .  A f te r  the  t ime per iod
as indicated in the f igure factors IXa YIIIa and
X were added and the rate of factor X activation
detennined as described in table 3.
Table 3 surumarizes the resul ts of  a l l  physiological  st imulants tested. He
f ind  the  s t ronges t  s t imu la t ion  by  co l lagen  p lus  th romb in .  The  non-
physiological  t r igger,  the calc ium ionophore A23187 is even more act ive.
The resul ts can not be at t r ibuted to lysis s ince the platelets remain
in tac t  dur ing  ac t iva t ion ,  and less  than 37 ,  o f  p la te le t  LDH is  re leased
dur ing  s t imu l  a t ion .
/-T-\
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0.4
0.8
2.5
6.0
19.4
0.1
Table 3:  Ef fect  of  p latelets on intr insic factor X act ivat ion.  Platelet
act' ivation was for 10 minutes at 37 0C, factor Xa formation was determined'
from the amount of factor Xa present after 45 and 90 sec. The final
concentrat ions of  c lot t ing factors in react ionmixture were: factor IXa, 50
nM;  fac to r  V I I Ia ,  0 .1  nM;  fac to r  X ,  0 .5  uM.
Our explanat ion for  the appearance of  p latelet  act iv i ty in factor X
act ivat ion is that  af ter  t r igger ing by col lagen plus thrombin procoagulant
negat ive' ly charged phosphol ip ids have become avai lable at  the platelet
surface. This is supported by several  l ines'of  evidence:
i t .  Col iagen and thrombin act ivated platelets subst i tute for  procoagulant
phospho l ip id  ves ic les  in  fac to r  X  ac t iva t ion .
b.  The act iv i ty of  act ivated platelets is abol ished af ter  phosphol ipase A2
d iges t ion  (w i thout  p la te le t  l ys is ) ( taUle  3) .
c. Direct analysis of the platelet outer surface by non-lytic degradation
with phosphol ipase A2 shows that 25X of  the platelet  phosphat idylser ine
has become avai lable at  the platelet  outer surface. (Bevers et  a l  ref .
g ) .
l. le propose the following model for appearance of platelet procoagulant
ac t i v i t y  (F ig .11) .
*
*
*
t
Platelet st imulator Rate of fXa formation (nM/min) St
' --:7-"--
Unstimul ated
Thrombin (-1.3 nM)
Co]lagen (10 rrg/ml )
Thrombin p lus co l lagen
A23187 (1 uM)
Thrombin p lus co l lagen fo l lowed
by incubation with phosphol ipase A2
t
7
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I IODEL  FOR PLATELET  PROCOAGULANT ACT IV ITY
O u l r i d G
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I  cot t re cn r  Thtombln Fig .  l l  Hode l  fo r  the  appearance,o f  p la te le t
p r6coagu lan t  ac t i v i t y .  Schemat ica l l y -shmn is
the platelet plasma menbrane l ipid bi layer.
The f i l led circles in the bi layer denote nega-
t ively charged polar head groups of-procoagu-
lan t  phospho l ip id '  e .g '  phosphat idy lser ine
(PS) ,  tha t  in te rac t  w i th  c lo t t ing  fac to rs '
p la te le t  s t imu la t ion  w i th  Co l lagen and l Ia
results in PS exposure' result ing from PS
transport from the inside to the Platelet out-
s ide  ( f l ip - f lop  hypothes is ;  fo r  de ta i l s  see
ref. 8.
In  the  uns t imu la ted  p la te le t  the  procoagu lan t  phospho l ip id ,  phosphat idy l -
ser ine  PS is  loca ted  a t  the  p la te le t  ins ide .  Tr igger ing  by  co l lagen p lus
thrombin leads to appearance of  PS at  the p ' latelet  outs ide. the t ranslayer
transport  of  PS ( f l ip- f top) may be faci l i tated by proteins.  Hembrane
proteins may be present that  have af f in i ty for  PS, such that domains wi th a
high PS content are formed. As could not be shown here,  act ivated platelets
also st imulate the act ivat ion of  prothrombin into thrombin by factor Xa and
Va.  Bevers  e t  a l  (9 ) .  A  de ta i led  s tudy  on  the  ac t iv i t y  o f  p la te le ts  in
factor X and prothrombin act ivat ion is for thcoming. (Van Ri jn et  a l .
Manuscr ip t  in  p repara t ion) .
:-
Importance of  intr insic factor X act ivat ion in c lot t ing pathways.
In t r ins ic  fac to r  X  ac t i va t ion  mus t  be  a  phys io log ica l  impor tan t
mechanism consider ing the ser iousness of  factors VII I  and IX def ic iencies.
However the intr insic and extr insic c lot t ing pathways do not readi ly
explain th is prominence (Fig.  12).
The extr insic pathway of  factor X act ivat ion bypasses the intr insic
route and does not explain why haemophi l ia is a disorder.  The intr insic
pathway explains the importance of  factors IX and VII I ,  but  leaves no role
for thromboplast in release as in i t iator of  c lot t ing.  The importance of  the
contactsystem for the in i t iat ion of  c lot t ing is fur ther compl icated by the
fac t  tha t  de f ic ienc ies  in  fac to r  X I I ,  h igh  molecu la r  we igh t  k in inogen,  and
prekal l ikrein are not major bleeding disorders.  The al ternat ive pathway was
discovered by psterud and Rapaport in 1977, who showed that factor IX can
-  11 -
be act ivated to factor IXa by thromboplast in and factor VIIa (10).  This
pathway leaves a role for  factors IX and Vl l l , -however i t  must be explained
rvhy the indirect  a l ternat ive route should be advantagbous over direct
factor X act ivat ion.
EXTRINSIC PATHWAY
th.6boglr.lh
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Fig. 12 i t lajor clott ing pathways in plasma.
The answer may be ampl i f icat ion.  Jesty and Si lverberg (11) have
determined that with a given amount of thromboplastin, factor Xa is formed
at 6-fold higher rates as factor IXa. However,  our resul ts ( table 1)
indicate that  under opt imal condi t ions,  each molecule of  factor IXa
produces 500 molecules of factor Xa per minute. Therefore, the alternative
pathway may produce factor Xa at 100 fo'ld higher rates as the direct
extr insic pathway.
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